 |
|

Search "Organon"
|

|
Organon | |
|
About 7 pages (2,033 words) in 2 products |
|

Encyclopedia and Summary Information
summary from source:

Aristotelian Logic Summary
757 words, approx. 3 pages Aristotle (384-322 B.C.), a student of Plato and tutor of Alexander the Great, invented a system of logic which remained essentially unchanged in Western European philosophy for more than two millennia following his death. Although his predecessors,...
summary from source:

Organon Information
1,276 words, approx. 4 pages
 The Organon is the name given by Aristotle's followers, the Peripatetics, to the standard collection of six of his works on logic. The works are Categories, Prior Analytics, De Interpretatione, Posterior Analytics, Sophistical Refutations, and...




summary from source:
 Chain Drug Review
Organon.
03/15/1999: 311 words, approx. 1 pages Women's health care is the primary focus for Organon Inc., which manufactures branded pharmaceutical products for contraception. fertility, hormone replacement therapy (HRT) and depression. "Women's health is something we're emphasizing now and will continue to emphasize in the near future," says vice...
summary from source:
 Pharmaceutical Executive
No IPO for Organon
04/01/2007: 1,506 words, approx. 5 pages Akzo Nobel sells its pharma subsidiary to Schering-Plough. Plus, Jazz registers for an IPO, Eli Lilly acquires a sleep specialist, Dendrite joins France's Cegedim, and other key recent deals. Akzo Nobel's plans tu spin off its Organon Biosciences unit through an initial public...
summary from source:
 Investor's Business Daily
Organon Buyout Fattens Schering's Pipeline
3/16/2007: 723 words, approx. 2 pages Among major U.S. drug stocks, Schering-Plough tends to fly under the radar of better-known peers such as Pfizer and Merck.That changed last week when Schering SGP said it would pay about $14.4 billion for Organon BioSciences, a unit of Dutch chemical and drug conglomerate Akzo...
summary from source:
 AP Features
Schering-Plough must sell veterinary medicines to win EU OK to buy Akzo unit
10/11/2007: 304 words, approx. 1 pages U.S. pharmaceutical company Schering-Plough Corp. has agreed to sell off several animal vaccines and medicines to win EU approval to acquire Organon Biosciences, the drug unit of Netherlands-based Akzo Nobel NV, for $14.4 billion (10.95 billion euros).The European Commission said Thursday it had cleared Schering-Plough...


|
Organon | |
|
About 7 pages (2,033 words) in 2 products |
|
|
|


|
|  |
 |
|  |